SCHEMBL1070950

SCHEMBL1070950

C=C(C)C(=O)NC(C)N1CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
PKM P14618 1/20 0.42
TGFBR1 P36897 1/20 0.36
ALDH1A1 P00352 4/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TSHR P16473 3/20 0.34
POLB P06746 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
ALOX15 P16050 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7615098 0.81 TGFBR1 (0.37) TGFBR1ALDH1A1KMT2ATSHRKDM4E
SCHEMBL8065835 0.80 ALDH1A1 (0.40) SMN1; SMN2PKMTGFBR1ALDH1A1LMNA
SCHEMBL733022 0.79 CHRM5 (0.40) TGFBR1
SCHEMBL6396274 0.78 SMN1; SMN2 (0.47) SMN1; SMN2PKMALDH1A1LMNAMAPT
SCHEMBL9807354 0.77 ALDH1A1 (0.36) TGFBR1ALDH1A1TSHRCYP3A4CYP2C19
SCHEMBL1070614 0.76 TSHR (0.47) SMN1; SMN2PKMALDH1A1LMNAMAPT
SCHEMBL6628443 0.74 SMN1; SMN2 (0.43) SMN1; SMN2PKMALDH1A1LMNAMAPT
SCHEMBL2697887 0.74 SMN1; SMN2 (0.47) SMN1; SMN2PKMALDH1A1LMNAMAPT
SCHEMBL14166869 0.72 ALDH1A1 (0.52) SMN1; SMN2PKMALDH1A1LMNAMAPT
SCHEMBL1147606 0.71 CYP2D6 (0.45) SMN1; SMN2KMT2ARAB9APOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10551345-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2020-02-04 US claimed
US-20170356877-A1 POLY AND COPOLY(N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS, LLC (US) 2017-12-14 US claimed
US-9671367-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2017-06-06 US claimed
US-20150159009-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS LLC (US) 2015-06-11 US claimed
US-20140209461-A1 Poly and Copoly(N-vinylamide)s and Their Use In Capillary Electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2014-07-31 US claimed
US-20130153421-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS, LLC (US) 2013-06-20 US claimed
EP-2053067-B1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS LLC (US) 2011-09-14 EP claimed
EP-2275463-A1 Support for electrophoresis containing a composition and method Life Technologies Corporation (US) 2011-01-19 EP claimed
EP-1539846-B1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS LIFE TECHNOLOGIES CORP (US) 2010-09-08 EP claimed
US-20100051461-A1 Poly and Copolyn(N-Vinylamide)s and their use in Capillary Electrophoresis Life Technologies Corporation (US) 2010-03-04 US claimed
EP-2053067-A1 Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis Applied Biosystems Inc. (US) 2009-04-29 EP claimed
EP-1636279-B1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLIED BIOSYSTEMS (US) 2009-02-18 EP claimed
EP-1636279-A1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS Applera Corporation (US) 2006-03-22 EP claimed
US-20050234166-A1 Graft copolymers, their preparation and use in capillary electrophoresis APPLIED BIOSYSTEMS, INC. 2005-10-20 US claimed
EP-1539846-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS Applera Corporation (US) 2005-06-15 EP claimed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 US claimed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 WO claimed
WO-2004011513-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-02-05 WO claimed
US-10551345-B2 Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis APPLIED BIOSYSTEMS, LLC (US) 2020-02-04 US disclosed
WO-2004011513-A1 GRAFT COPOLYMERS, THEIR PREPARATION AND USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides POLI, PCNA, POLL SMN1; SMN2 963/4885PKM 1372/4885TGFBR1 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.